Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy
- 1 February 2009
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 66 (2) , 255-258
Abstract
Case Report from JAMA Neurology — Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal LeukoencephalopathyKeywords
This publication has 8 references indexed in Scilit:
- Mirtazapine in Progressive Multifocal Leukoencephalopathy Associated with Polycythemia VeraThe Journal of Infectious Diseases, 2007
- Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositisJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Evaluation of Patients Treated with Natalizumab for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2006
- Mechanism of JCV Entry into OligodendrocytesScience, 2005
- Mirtazapine: a review of its clinical efficacy and tolerabilityExpert Opinion on Pharmacotherapy, 2005
- The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect CellsScience, 2004
- Mirtazapine for Depression in Patients With Human Immunodeficiency VirusJournal of Clinical Psychopharmacology, 2000
- Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-Interferon: an observational studyJournal of NeuroVirology, 1998